XML 73 R23.htm IDEA: XBRL DOCUMENT
v2.4.0.8

17. Parent Company Financial Statements (Unaudited) | 12 Months Ended
--- | ---
Dec. 31, 2013
Condensed Financial Information of Parent Company Only Disclosure [Abstract] |
17. Parent Company Financial Statements (Unaudited) | The following is a summary of the Parent Company financial statements for the years ended December 31, 2013 and 2012: Aemetis, Inc. (Parent Company) Consolidated Balance Sheets As of December 31, 2013 and 2012
Assets |  | 2013 |  |  | 2012 |  |  |
Current assets |  |  |  |  |  |  |  |
Cash and cash equivalents |  | $ | 13,718 |  |  | $ | - |  |  |
Intercompany receivables |  |  | 27,627,159 |  |  |  | 20,802,877 |  |  |
Total current assets |  |  | 27,640,877 |  |  |  | 20,802,877 |  |  |
Investments in Subsidiaries, net of advances |  |  |  |  |  |  |  |  |  |
Investment in Aemetis International, Inc. |  |  | 2,678,525 |  |  |  | 3,060,684 |  |  |
Investment in Aemetis Americas, Inc |  |  | - |  |  |  | 116,144 |  |  |
Total investments in Subsidiaries, net of advances |  |  | 2,678,525 |  |  |  | 3,176,828 |  |  |
Other assets |  |  | 23,095 |  |  |  | 23,095 |  |  |
Total Assets |  | $ | 30,342,497 |  |  | $ | 24,002,800 |  |  |
Liabilities & stockholders' equity(deficit) |  |  |  |  |  |  |  |  |  |
Current liabilities |  |  |  |  |  |  |  |  |  |
Accounts payable |  | $ | 3,397,294 |  |  | $ | 4,037,137 |  |  |
Outstanding checks in excess of cash |  |  | - |  |  |  | 25,773 |  |  |
Mandatorily redeemable Series B convertibe preferred |  |  | 2,539,528 |  |  |  | 2,437,649 |  |  |
Other current liabilities |  |  | 1,677,835 |  |  |  | 2,174,608 |  |  |
Total current liabilities |  |  | 7,614,657 |  |  |  | 8,675,167 |  |  |
Subsidiary obligation in excess of investment |  |  |  |  |  |  |  |  |  |
Investment in AE Advanced Fuels, Inc. |  |  | 31,324,660 |  |  |  | 8,400,675 |  |  |
Investment in Aemetis Americas, Inc |  |  | 246,676 |  |  |  | - |  |  |
Investment in Aemetis Biofuels, Inc. |  |  | 2,741,279 |  |  |  | 2,624,575 |  |  |
Investment in Aemetis Technologies, Inc. |  |  | 833,318 |  |  |  | 438,375 |  |  |
Investment in Biofuels Marketing, Inc. |  |  | 349,056 |  |  |  | 349,056 |  |  |
Total subsidiary obligation in excess of investment |  |  | 35,494,989 |  |  |  | 11,812,681 |  |  |
Total long term liabilities |  |  | 35,494,989 |  |  |  | 11,812,681 |  |  |
Stockholders' equity(deficit) |  |  |  |  |  |  |  |  |  |
Series B Preferred convertible stock |  |  | 2,401 |  |  |  | 3,098 |  |  |
Common stock |  |  | 199,737 |  |  |  | 180,281 |  |  |
Additional paid-in capital |  |  | 84,192,552 |  |  |  | 75,457,760 |  |  |
Accumulated deficit |  |  | (94,245,503 | ) |  |  | (69,808,294 | ) |  | )
Accumulated other comprehensive loss |  |  | (2,916,336 | ) |  |  | (2,317,893 | ) |  | )
Total stockholders' equity(deficit) |  |  | (12,767,149 | ) |  |  | 3,514,952 |  |  | )
Total liabilities & stockholders' equity(deficit) |  | $ | 30,342,497 |  |  | $ | 24,002,800 |  |  |
Aemetis, Inc. (Parent Company) Consolidated Statements of Operations and Comprehensive Loss For the Years Ended December 31, 2013 and 2012
|  |  |  | 2013 |  | 2012
Equity in subsidiary losses |  |  | $ (22,134,091) |  | $ (12,496)
Selling, general and administrative expenses |  | 2,686,828 |  | 2,302,944
Operating loss |  |  |  | (24,820,919) |  | (2,315,440)
Other income/(expense) |  |  |  |  |
| Interest expense |  | (187,417) |  | (1,865,803)
| Other income/(expense) |  | 576,892 |  | (97,022)
Loss before income taxes |  |  | (24,431,444) |  | (4,278,265)
| Income taxes expense |  | (5,765) |  | (4,000)
Net loss |  |  |  | $ (24,437,209) |  | $ (4,282,265)
Other comprehensive loss |  |  |  |  |
| Foreign currency translation adjustment | (598,443) |  | (74,531)
Comprehensive loss |  |  | $ (25,035,652) |  | $ (4,356,796)
Aemetis, Inc. (Parent Company) Consolidated Statements of Cash Flows For the years ended December 31, 2013 and 2012
|  | 2013 |  |  | 2012 |
Operating activities: |  |  |  |  |  |
Net loss |  |  | (24,437,209 | ) |  |  | (4,282,265 | )
Adjustments to reconcile net loss to |  |  |  |  |  |  |  |
net cash provided/(used) in operating activities: |  |  |  |  |  |  |  |
Stock-based compensation |  |  | 1,760,072 |  |  |  | 686,059 |
Amortization of debt issuance discount |  |  | - |  |  |  | 400,997 |
Change in fair value of warrant liability |  |  | (197,127 | ) |  |  | 97,022 |
Changes in assets and liabilities: |  |  |  |  |  |  |  |
Subsidiary portion of net losses |  |  | 22,134,091 |  |  |  | 12,496 |
Prepaid expenses |  |  | - |  |  |  | 4,668 |
Accounts payable |  |  | (639,843 | ) |  |  | 236,887 |
Accrued interest expense |  |  | - |  |  |  | 682,983 |
Other liabilities |  |  | (177,896 | ) |  |  | 288,203 |
Net cash used in operating activities |  |  | (1,557,912 | ) |  |  | (1,872,950 | )
Investing activities: |  |  |  |  |  |  |  |
Change in outstanding checks in excess of cash |  |  | (25,773 | ) |  |  | 25,773 |
Subsidiary advances, net |  |  | 514,668 |  |  |  | 9,417,256 |
Net cash provided in investing activities |  |  | 488,895 |  |  |  | 9,443,029 |
Financing activities: |  |  |  |  |  |  |  |
Proceeds from borrowings under secured debt facilities |  |  | - |  |  |  | 840,000 |
Repayments of borrowings under secured debt facilities |  |  | - |  |  |  | (8,412,259 | )
Equity Offering |  |  | 1,075,200 |  |  |  | - |
Warrants exercised |  |  | 7,535 |  |  |  | 1,433 |
Net cash provided by/(used in)by financing activities |  |  | 1,082,735 |  |  |  | (7,570,826 | )
Net increase/(decrease) in cash and cash equivalents |  |  | 13,718 |  |  |  | (747 | )
Cash and cash equivalents at beginning of period |  |  | - |  |  |  | 747 |
Cash and cash equivalents at end of period |  | $ | 13,718 |  |  | $ | - |
Supplemental disclosures of cash flow information, cash paid: |  |  |  |  |  |  |  |
Interest payments |  |  | 4,522,097 |  |  |  | 2,084,751 |
Income tax expense |  |  | 5,765 |  |  |  | 4,000 |
Supplemental disclosures of cash flow information, non-cash transactions: |  |  |  |  |
Issuance of warrants to non-employees to secure procurement and working capital |  |  | 335,617 |  |  |  |  |
Issuance of warrants to subordinated debt holders |  |  | 1,127,120 |  |  |  |  |
Issuance of shares for acquisition |  |  | - |  |  |  | 12,511,200 |
Payments of principal, fees and interest by issuance of stock |  |  | 3,616,284 |  |  |  | 11,885,579 |
Issuance of shares to related party for repayment of line of credit |  |  | 821,946 |  |  |  | 4,107,141 |
Beneficial conversion discount on related party debt |  |  | - |  |  |  | 884,851 |
Other asset transferred to related party |  |  | 170,000 |  |  |  |  |
Warrant liability transferred to equity upon exercise |  |  | 1,006,648 |  |  |  |  |

X
- Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for condensed financial information, including the financial position, cash flows, and the results of operations of the registrant (parent company) as of the same dates or for the same periods for which audited consolidated financial statements are being presented. Alternatively, the details of this disclosure can be reported by the specific parent company taxonomy elements, indicating the appropriate date and period contexts in an instance document. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 06 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-04) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e24072-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7656940&loc=d3e5283-111683 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 12 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph c -Article 5 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 05 -Paragraph c -Article 7 + Details
Name: | us-gaap_CondensedFinancialInformationOfParentCompanyOnlyDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration